GRCE
Grace Therapeutics, Inc.$2.23-0.07 (-2.84%)Prev Close$2.29·MCap$55.5M·P/E—·Vol53.8K·Yield—
▲
Buys (12M)
3
$270.1K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$270.1K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Grace Therapeutics, Inc. (GRCE) has been exclusively buying, with 3 insider purchases totaling $270.1K and 0 insider sales totaling $0.00. The most recent insider transaction was by Kohli Prashant (director, officer: Chief Executive Officer), who purchased $214.0K worth of shares on Sep 10, 2026. Grace Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $55.5M.
GRCE Insider Trading Activity
GRCE Insider Buying Activity
The following table shows recent insider purchases of Grace Therapeutics, Inc. (GRCE) stock reported via SEC Form 4 filings.
GRCE Insider Selling Activity
The following table shows recent insider sales of Grace Therapeutics, Inc. (GRCE) stock reported via SEC Form 4 filings.
No insider selling activity found for GRCE in the last 12 months.